Two novel platinum(ii) complexes, [PtCl2(H-MeOBC)(DMSO)] (Pt1) and [Pt2Cl3(MeOBC)(DMSO)2] (Pt2), with 3-(2'-benzimidazolyl)-8-methoxycoumarin (H-MeOBC) as the ligand were synthesized and evaluated for their antiproliferative activity. Among all the tumor cells, dual-Pt(ii) complex Pt2 exhibited the most potent activity, with an IC50 value of 0.5 ± 0.2 μM against cisplatin-resistant SK-OV-3/DDP cancer cells. In the case of SK-OV-3/DDP cells, Pt2 displayed a 20.1-196.0-fold increased activity when compared with cisplatin, H-MeOBC and Pt1. Importantly, Pt1 and Pt2 displayed low inhibitory rates against normal HL-7702 cells. Further investigation revealed that Pt2 is a novel telomerase inhibitor binding to c-myc promoter elements. Mechanistic studies demonstrated that dual-Pt(ii) complex Pt2 arrests the cell cycle at the G2/M phase and induces apoptosis and causes mitochondrial dysfunction.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1039/c8mt00125a | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Platinum(II/IV) complexes with -substituted carboxylate ethylenediamine/propylenediamine ligands: preparation, characterization and activity.
Dalton Trans
January 2025
Department of Chemistry, Babeş-Bolyai University, Str. Arany Janos Nr. 11, RO-400028 Cluj-Napoca, Romania.
The synthesis and characterization of novel platinum(II) and platinum(IV) complexes derived from unsymmetrical ethylene or propylenediamine derivatives are presented. IR spectroscopy and ESI mass spectrometry techniques were employed to characterize the complexes, revealing distinctive absorption bands and isotope patterns. Furthermore, the complexes were characterized by H and C NMR spectroscopy.
View Article and Find Full Text PDFVibrational and DFT Studies and Anticancer Activity of Novel Pd(II) and Pt(II) Complexes with Chloro Derivatives of 7-Azaindole-3-Carbaldehyde.
Molecules
December 2024
Institute of Chemistry, Faculty of Science and Technology, Jan Dlugosz University in Czestochowa, Armii Krajowej 13/15, 42-200 Czestochowa, Poland.
This study investigates the structural, vibrational, and biological properties of novel palladium(II) and platinum(II) complexes with 5-chloro-7-azaindole-3-carbaldehyde (5ClL) and 4-chloro-7-azaindole-3-carbaldehyde (4ClL) ligands. Infrared and Raman spectroscopy, combined with DFT (ωB97X-D) calculations, provided valuable information about metal-ligand interactions, the or conformation of the aldehyde group in the ligands, and the presence of isomers in the metal complexes obtained in the solid state. tests were used to evaluate the antiproliferative activity of the novel complexes against several cancer cell lines, including ovarian cancer (A2780), cisplatin-resistant ovarian cancer (A2780cis), colon cancer (HT-29), and triple-negative breast cancer (MDA-MB-231), as well as normal mouse fibroblasts (BALB/3T3).
View Article and Find Full Text PDFA novel platinum(II) complex with a berberine derivative as a potential antitumor agent targeting G-quadruplex DNA.
Org Biomol Chem
December 2024
College of Marine Sciences, Beibu Gulf University, Qinzhou, China.
Article Synopsis
- - G-quadruplexes are important for cancer therapy, and understanding how compounds (ligands) interact with them is key for developing new anticancer drugs.
- - A new platinum(II) complex (Pt1) was created using a berberine derivative as a ligand, and its structure was studied using various scientific methods.
- - The study found that Pt1 binds well to G-quadruplex DNA, especially targeting the bcl-2 G-quadruplex, and showed effectiveness in inhibiting the growth of different tumor cells, indicating its potential as an antitumor agent.
Synthesis of novel pyrimidine-based Schiff base complexes: Targeting Amyloid-β aggregation in Alzheimer's disease.
Bioorg Chem
November 2024
Department of Chemistry, Faculty of Science, Ege University, Bornova, Izmir 35100, Turkey. Electronic address:
Article Synopsis
- A novel Schiff base compound, 5-((3,3-diphenylalilidene)amino)pyrimidine-4-amine (L), was synthesized along with new platinum and ruthenium complexes, which were characterized through various analytical techniques.
- * The complexes demonstrated a strong ability to inhibit amyloid beta (Aβ) aggregation in human neuroblastoma cells (SH-SY5Y), significantly improving cell viability by up to 80% at 10 μM concentration compared to Aβ aggregation alone.
- * Further investigations using advanced microscopy and spectroscopy techniques confirmed that these metal complexes actively engage with Aβ and effectively inhibit its aggregation.
1D, 3D supramolecular assemblies of a series of cyclometalated platinum(II) complexes with deep-red aggregation-induced phosphorescent emission and anion turn-on sensing via Pt-Pt interaction.
Biosens Bioelectron
January 2025
Faculty of Life Science and Technology, Kunming University of Science and Technology, Kunming, 650500, PR China. Electronic address:
Controlling the size and morphology of supramolecular assemblies is still an enormous challenge for the development of novel functional materials. Herein, cyclometalated platinum(II) complexes were designed and used as effective theragnostic supramolecular nano agents. Benzoquinoline was used as the main C^N ligand, and the increased number of aromatic rings in the N^N ligand of Pt complexes could greatly improve lipophilicity and cytotoxicity towards cancer cells over normal cells.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!